SEC Form 4 · accession 0001645627-18-000012
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Feb 23, 2018
Accepted (ET)
Feb 28, 2018 · 12:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2018 | P | 1,000 | $0.044 | A | 24,832,189 | D | |
| Common Stock | Feb 23, 2018 | P | 1,000 | $0.045 | A | 24,833,189 | D | |
| Common Stock | Feb 26, 2018 | P | 1,000 | $0.0445 | A | 24,834,189 | D | |
| Common Stock | Feb 26, 2018 | P | 1,000 | $0.044 | A | 24,835,189 | D | |
| Common Stock | Feb 26, 2018 | P | 1,000 | $0.044 | A | 24,836,189 | D | |
| Common Stock | Feb 26, 2018 | P | 1,000 | $0.044 | A | 24,837,189 | D |
Table II — derivative securities
No Table II lines on this filing.